Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celyvir in Metastatic and Refractory Solid Tumors
NCT01844661Phase 2Completed
- Sponsor
- Hospital Universitario Niño Jesús
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Celyvir in solid tumor, sponsored by Hospital Universitario Niño Jesús. Started Jan 2013; status: completed.
02
Drugs
Celyvir
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01844661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844661.